Infants With Protein Sensitive Colitis
Evaluation of an Elemental Formula in Infants With Protein Sensitive Colitis
1 other identifier
interventional
53
1 country
2
Brief Summary
Infants with protein sensitive colitis fed a nutritionally complete free amino acid-based medical food will be evaluated for 42 days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 1999
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 1999
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2001
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2001
CompletedFirst Submitted
Initial submission to the registry
March 14, 2013
CompletedFirst Posted
Study publicly available on registry
March 19, 2013
CompletedMarch 19, 2013
March 1, 2013
1.3 years
March 14, 2013
March 15, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Physician Rated Symptom Score
Calculated from a symptom checklist based on parent report of the previous 7 day history; Change in physician rated symptom score from SD 1 to SD 43.
Study Day (SD) 1 and 43
Secondary Outcomes (5)
Mean Rank Stool Consistency
Study Day (SD) 2-4 and 40-42
Weight
Study Day (SD) 1 and 43 Visits
Formula Intake
Study Day (SD) 2-4 and 40-42
Daily Stool Number
Study Day (SD) 2-4 and 40-42
Stool Occult Blood
Study Day (SD) 2-4 and 40-42
Study Arms (1)
Experimental Infant Formula
EXPERIMENTALExperimental formula to be fed ad libitum.
Interventions
Nutritionally complete free amino acid-based medical food.
Eligibility Criteria
You may qualify if:
- Less than or equal to 6 months of age
- weeks gestational age at birth
- Singleton or Twin birth
- Diagnosed with protein sensitive colitis
- Negative stool culture at time of study entry
- No previous history of consuming free amino acid-based medical food
- Not receiving cisapride or steroids
- No vitamin mineral supplement administration during the study period with the exception of iron or fluoride
- No milk or soy products for the duration of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Abbott Nutritionlead
Study Sites (2)
Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
Children's Hospital
Omaha, Nebraska, 68114, United States
Related Publications (1)
Amari S, Shahrook S, Namba F, Ota E, Mori R. Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates. Cochrane Database Syst Rev. 2020 Oct 2;10(10):CD012273. doi: 10.1002/14651858.CD012273.pub2.
PMID: 33006765DERIVED
Study Officials
- STUDY CHAIR
Marlene Borschel, PhD, RD
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 14, 2013
First Posted
March 19, 2013
Study Start
November 1, 1999
Primary Completion
February 1, 2001
Study Completion
February 1, 2001
Last Updated
March 19, 2013
Record last verified: 2013-03